Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 45

1.

Reduced vesicular storage of dopamine causes progressive nigrostriatal neurodegeneration.

Caudle WM, Richardson JR, Wang MZ, Taylor TN, Guillot TS, McCormack AL, Colebrooke RE, Di Monte DA, Emson PC, Miller GW.

J Neurosci. 2007 Jul 25;27(30):8138-48.

2.

New insights into the mechanism of action of amphetamines.

Fleckenstein AE, Volz TJ, Riddle EL, Gibb JW, Hanson GR.

Annu Rev Pharmacol Toxicol. 2007;47:681-98. Review.

PMID:
17209801
3.
4.

Dopamine transporter activity mediates amphetamine-induced inhibition of Akt through a Ca2+/calmodulin-dependent kinase II-dependent mechanism.

Wei Y, Williams JM, Dipace C, Sung U, Javitch JA, Galli A, Saunders C.

Mol Pharmacol. 2007 Mar;71(3):835-42. Epub 2006 Dec 12.

5.

Binge administration of 3,4-methylenedioxymethamphetamine ("ecstasy") impairs the survival of neural precursors in adult rat dentate gyrus.

Hernández-Rabaza V, Domínguez-Escribà L, Barcia JA, Rosel JF, Romero FJ, García-Verdugo JM, Canales JJ.

Neuropharmacology. 2006 Oct;51(5):967-73. Epub 2006 Sep 1.

PMID:
16949621
6.

MDMA administration to pregnant Sprague-Dawley rats results in its passage to the fetal compartment.

Campbell NG, Koprich JB, Kanaan NM, Lipton JW.

Neurotoxicol Teratol. 2006 Jul-Aug;28(4):459-65. Epub 2006 Jun 8.

PMID:
16905291
7.

Methylphenidate exerts no neurotoxic, but neuroprotective effects in vitro.

Ludolph AG, Schaz U, Storch A, Liebau S, Fegert JM, Boeckers TM.

J Neural Transm (Vienna). 2006 Dec;113(12):1927-34. Epub 2006 Jun 1.

PMID:
16736241
8.

Regulation of the dopamine transporter by phosphorylation.

Foster JD, Cervinski MA, Gorentla BK, Vaughan RA.

Handb Exp Pharmacol. 2006;(175):197-214. Review.

PMID:
16722237
9.

3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings.

Baumann MH, Wang X, Rothman RB.

Psychopharmacology (Berl). 2007 Jan;189(4):407-24. Epub 2006 Mar 16. Review.

10.

Tetrazolium dyes as tools in cell biology: new insights into their cellular reduction.

Berridge MV, Herst PM, Tan AS.

Biotechnol Annu Rev. 2005;11:127-52. Review.

PMID:
16216776
11.

Neurotoxicity of Ecstasy metabolites in rat cortical neurons, and influence of hyperthermia.

Capela JP, Meisel A, Abreu AR, Branco PS, Ferreira LM, Lobo AM, Remião F, Bastos ML, Carvalho F.

J Pharmacol Exp Ther. 2006 Jan;316(1):53-61. Epub 2005 Sep 23.

12.

Mechanisms of neurotransmitter release by amphetamines: a review.

Sulzer D, Sonders MS, Poulsen NW, Galli A.

Prog Neurobiol. 2005 Apr;75(6):406-33. Review.

PMID:
15955613
13.

Prenatal 3,4-methylenedioxymethamphetamine (ecstasy) exposure induces long-term alterations in the dopaminergic and serotonergic functions in the rat.

Galineau L, Belzung C, Kodas E, Bodard S, Guilloteau D, Chalon S.

Brain Res Dev Brain Res. 2005 Feb 8;154(2):165-76. Epub 2004 Dec 16.

PMID:
15707670
14.
15.

Interference with anoikis-induced cell death of dopamine neurons: implications for augmenting embryonic graft survival in a rat model of Parkinson's disease.

Marchionini DM, Collier TJ, Camargo M, McGuire S, Pitzer M, Sortwell CE.

J Comp Neurol. 2003 Sep 15;464(2):172-9.

PMID:
12898610
16.

The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").

Green AR, Mechan AO, Elliott JM, O'Shea E, Colado MI.

Pharmacol Rev. 2003 Sep;55(3):463-508. Epub 2003 Jul 17. Review.

17.

Cellular models to study dopaminergic injury responses.

Collier TJ, Steece-Collier K, McGuire S, Sortwell CE.

Ann N Y Acad Sci. 2003 Jun;991:140-51. Review.

PMID:
12846983
18.

Strategies for the augmentation of grafted dopamine neuron survival.

Sortwell CE.

Front Biosci. 2003 May 1;8:s522-32. Review.

PMID:
12700087
19.

Oxidative stress in Parkinson's disease.

Jenner P.

Ann Neurol. 2003;53 Suppl 3:S26-36; discussion S36-8. Review.

PMID:
12666096
20.

Dopamine transporter-mediated conductances increase excitability of midbrain dopamine neurons.

Ingram SL, Prasad BM, Amara SG.

Nat Neurosci. 2002 Oct;5(10):971-8.

PMID:
12352983

Supplemental Content

Support Center